Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2641,"Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331.",glomerular filtration trait,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,91 days,10,,CMO:0001211,creatinine clearance to body weight ratio,,,,0.39,ml/min/100g,0.04,0.1265,MMO:0000271,serum creatinine analysis,,0.0,,,,,everolimus (0.83 mg/kg/d) (for 28 days),101878,everolimus (0.83 mg/kg/d) (for 28 days) 2641,"Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331.",glomerular filtration trait,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,12,,CMO:0001211,creatinine clearance to body weight ratio,,,,0.17,ml/min/100g,0.02,0.0693,MMO:0000271,serum creatinine analysis,,0.0,,,,,everolimus (0.83 mg/kg/d) (for 28 days),101880,everolimus (0.83 mg/kg/d) (for 28 days)